Yucca Partners L.P. Jersey Branch
10% owner at RPX Corp; 10% owner at Aegerion Pharmaceuticals, Inc.
- Sold, on record
- $17M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Feb 25, 2013
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- RPX Corp10% owner
- Aegerion Pharmaceuticals, Inc.10% owner
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- RPX Corp1.2M shares
- Aegerion Pharmaceuticals, Inc.86,788 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Aegerion Pharmaceuticals, Inc.Plan not statedJul 29, 2011 2011
Sold 36,788 shares at $14.61 ($537k)
Yucca Partners L.P. Jersey Branch, 10% owner
Sold 1.7% of holdings ($31.7M position)2.1M shares leftFirst sale on recordFiling
- 2 Form 4 sale Aegerion Pharmaceuticals, Inc.Plan not statedJan 30, 2012 +185 days
Sold 50,000 shares at $17.08 ($854k)
Yucca Partners L.P. Jersey Branch, 10% owner
Sold 2.3% of holdings ($36.4M position)2.1M shares leftFiling
- 3 Form 4 sale RPX CorpUnusualFeb 29, 2012 +30 days
Sold 122,709 shares at $17.68 ($2.2M)
Yucca Partners L.P. Jersey Branch, 10% owner
Sold 100% of holdings ($2.2M position)0 shares leftFirst sale on recordFiling
- 4 Form 4 sale RPX CorpPlan not statedMay 23, 2012 +84 days
Sold 20,000 shares at $12.78 ($256k)
Yucca Partners L.P. Jersey Branch, 10% owner
Sold 11% of holdings ($2.3M position)162,300 shares leftFiling
- 5 Form 4 sale RPX CorpUnusualFeb 25, 2013 +278 days
Sold 1.1M shares at $12.58 ($13.2M)
Yucca Partners L.P. Jersey Branch, 10% owner
Sold 97.7% of holdings ($13.5M position)24,734 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 25, 2013 | Feb 27, 2013 | RPX Corp | 10% owner | Form 4 sale | 1.1M | $13.2M | 97.7% | Unusual | SEC |
| May 23, 2012 | May 30, 2012 | RPX Corp | 10% owner | Form 4 sale | 20,000 | $256k | 11.0% | Plan not stated | SEC |
| Feb 29, 2012 | Mar 1, 2012 | RPX Corp | 10% owner | Form 4 sale | 122,709 | $2.2M | 100.0% | Unusual | SEC |
| Jan 30, 2012 | Feb 1, 2012 | Aegerion Pharmaceuticals, Inc. | 10% owner | Form 4 sale | 50,000 | $854k | 2.3% | Plan not stated | SEC |
| Jul 29, 2011 | Aug 2, 2011 | Aegerion Pharmaceuticals, Inc. | 10% owner | Form 4 sale | 36,788 | $537k | 1.7% | Plan not stated | SEC |